Inhibition of ACTH responsiveness of adrenocortical and fat cells adenylate cyclase by 4-methyl-4-aza-5 alpha-cholestane.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000273:Adipose Tissue / Q000201:enzymology* / Q000378:metabolism; D000302:Adrenal Cortex / Q000201:enzymology* / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001378:Azasteroids / Q000494:pharmacology*; D003994:Bucladesine / Q000494:pharmacology; D002462:Cell Membrane / Q000378:metabolism; D002776:Cholestanes / Q000494:pharmacology*; D000242:Cyclic AMP / Q000494:pharmacology; D004789:Enzyme Activation; D007700:Kinetics; D009928:Organ Specificity; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism; D013260:Steroids, Heterocyclic / Q000494:pharmacology*
D001378:Azasteroids; D002776:Cholestanes; D011956:Receptors, Cell Surface; D013260:Steroids, Heterocyclic; C025446:4-methyl-4-azacholestane; D003994:Bucladesine; D000324:Adrenocorticotropic Hormone; D000242:Cyclic AMP; D000262:Adenylyl Cyclases